AHERF EV Biofoundry — Diagnostics to CommercializationEV BiofoundryCliniConnectEV-Qual™ServicesStart an Enquiry
Governance & Quality

Governance and quality systems

Translational medicine requires a visible trust layer: ethics alignment, clinical governance, quality systems, IP clarity, data protection, sample governance and formal handoff where clinical trials are required.

Ethics & clinical governance

Protocol review, consent alignment, clinician interpretation and appropriate clinical-trial handoff.

Quality System (EV-Qual™)

QC gates, reproducibility, benchmarking, acceptance criteria and documentation-ready workflows.

IP & data governance

Background IP, new IP, data access, de-identification, sample-use rules and sharing approvals.

Governance overview
  • Ethical research conduct.
  • Quality-controlled workflows.
  • Responsible clinical translation.
  • Documentation-ready processes.
  • Clear routing of formal clinical trials where applicable.
Ethics & Clinical Governance

Human-subject research is protocol-based and ethics-aligned.

  • IEC / ethics review pathway.
  • Consent requirements.
  • Protocol-based sample and data use.
  • Human-subject research safeguards.
Clinical governance
  • Clinician engagement and disease-area review.
  • Clinical validation design and interpretation.
  • Clinical utility framing.
  • Formal clinical-trial handoff to Apollo Research Innovations where applicable.
Quality System (EV-Qual™)

The quality system links strongly with EV-Qual and other platform acceptance gates.

  • EV-Qual linkage.
  • QC thresholds and acceptance criteria.
  • Reproducibility checks.
  • Batch documentation.
  • Method lock and version control.
IP & Data Governance
  • Background IP clarity.
  • New IP from collaborative work.
  • Co-development IP arrangements.
  • Licensing pathway.
  • Founder/startup IP support where applicable.
Data governance
  • De-identification.
  • Access control.
  • Clinical metadata governance.
  • AI model documentation.
  • Data sharing rules and approvals.
Sample governance
  • Biospecimen collection and consent linkage.
  • Storage, tracking and access control.
  • Sample use restrictions.
  • Disease cohort governance.
  • Return, retention or disposal policy where applicable.
ARI clinical-trial handoff

AHERF-CMBRC supports translational, biomarker, platform, quality and validation-readiness activities. Formal clinical-trial pathways are coordinated through appropriate Apollo research channels where applicable.